SWSukhpreet Walia

Sukhpreet Walia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sukhpreet Walia has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Lower Yield of Endoscopic Ultrasound-Guided Fine-Needle Aspiration in Patients with Pancreatic Head Mass with a Biliary Stent

    by John J. Kim, Sukhpreet Walia, Scott H. Lee, Bhavesh Patel, Madhavi Vetsa, Yan Zhao, Wichit Srikureja, Loren Laine

    In jaundiced patients with suspected pancreatic cancer, endoscopic retrograde cholangiopancreatography (ERCP) with biliary stent is frequently performed prior to histologic diagnosis by endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA). To compare the accuracy of jaundiced patients undergoing EUS-FNA for a pancreatic mass with or without a biliary stent. Consecutive patients with a pancreatic mass and jaundice who underwent EUS-FNA between 4/2005 and 4/2013 were identified. Final diagnosis was based on histologic or radiologic evaluation with >6-month follow-up if the index EUS-FNA was negative for malignancy. Primary endpoint was histologic accuracy of EUS-FNA. Mean age of the 180 patients was 65 ± 12 years; 83 (46 %) had ERCP prior to EUS-FNA and 75 (42 %) received a biliary stent. Onsite cytopathologist was present for 81 (45 %) procedures. Final diagnosis revealed malignancy in 172 (96 %) patients, with adenocarcinoma in 159 (88 %). Patients with biliary stents had lower accuracy of EUS-FNA for malignancy than those without a biliary stent: 77 % (95 % CI 67–85 %) versus 89 % (95 % CI 81–93 %). On multivariate analysis, having a biliary stent (OR = 0.37, 95 % CI 0.15–0.90), onsite cytopathologist (OR = 9.24, 95 % CI 2.64–32.37), and receiving a core biopsy (OR = 2.60, 95 % CI 1.07–6.29) were associated with accuracy of EUS-FNA. Presence of a biliary stent was associated with a significant decrease in the accuracy of EUS-FNA for histologic diagnosis of pancreatic cancer, while accuracy was increased when a cytopathologist was onsite. EUS-FNA should be performed prior to ERCP in jaundiced patients with suspected pancreatic cancer.